NCT05238766

Brief Summary

Many children with autism demonstrate severe problem behavior (SPB) in the form of self-injury, aggression, and disruptive behavior. Conducting a functional analysis and implementing derived treatments can produce effective behavior plans. Nonetheless, skills training and an effective plan may not be sufficient to produce parent adherence. This applied research proposal describes an approach to target the negative maintaining contingencies supporting parent reinforcement of problem behavior (accommodation) and nonadherence. The intervention, borrowed from Acceptance and Commitment Therapy and Behavioral Activation strategies, is matched specifically to the hypothesized function of the problematic caregiver responses (negative reinforcement). Parents who participate in the proposed investigation will be assigned to either the Defuse Experience Accept Live intervention (DEAL) protocol group or treatment as usual. Five 45-min DEAL sessions will 1) introduce caregivers to behavior change strategies that maximize contact with positive-maintaining contingencies related to adherence, while undermining the contingencies that maintain accommodation, and 2) provide caregivers with new treatment-related committed actions that are sensitive to positive changes in parent-child interactions. Within and between participant analyses will be conducted to determine the effectiveness of the DEAL protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2022

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 19, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 14, 2022

Completed
4 months until next milestone

Study Start

First participant enrolled

June 21, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 4, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 4, 2024

Completed
Last Updated

February 28, 2025

Status Verified

February 1, 2025

Enrollment Period

2.4 years

First QC Date

January 19, 2022

Last Update Submit

February 26, 2025

Conditions

Keywords

Family AccommodationNonadherence

Outcome Measures

Primary Outcomes (4)

  • Accommodation to Adherence Change Score

    Conditional probabilities derived from a contingency space analysis

    Change from Time 1 (Week 1) to Time 2 (Week 7)

  • Experiential Avoidance

    The Acceptance and Action Questionnaire 2nd Edition (AAQ-II) assesses experiential avoidance (EA). The AAQ-II is a 7 item self-report instrument with a range of 7-49. Higher scores are indicative of higher levels of experiential avoidance.

    Change from Time 1 (Week 1) to Time 2 (Week 7)

  • Cognitive Fusion

    The Cognitive Fusion Questionnaire (CFQ) assesses cognitive fusion, or rigidly following self-generated rules. The CFQ is a 7 item self-report instrument with a range of 7-49. Higher scores are indicative of a higher level of cognitive fusion.

    Change from Time 1 (Week 1) to Time 2 (Week 7)

  • Parenting Stress

    The Parenting Stress Index - Short Form (PSI-SF) is a 36 item self-report instrument that measures parenting stress on a 5-point Likert scale. The Parental Distress subscale contains items that resemble statements that a parent might make about their own parenting skills. Self-statements oftentimes may function as rules, which we conceptualize as a more specific measure of parent cognitive fusion. Therefore, we consider high scores on this subscale to be reflective of parent-based cognitive fusion.

    Change from Time 1 (Week 1) to Time 2 (Week 7)

Study Arms (2)

Treatment as Usual

NO INTERVENTION

This arm does not receive any intervention. It will serve as a comparison for the experimental arm.

Treatment + DEAL

EXPERIMENTAL

Parents in the Treatment plus Defuse Experience Accept Live (T+DEAL) arm will attend five 45-min DEAL sessions with a therapist. Across the five sessions, the therapist will 1) introduce caregivers to behavior change strategies that maximize contact with positive-maintaining contingencies related to adherence, while undermining the contingencies that maintain accommodation, and 2) provide caregivers with new treatment-related committed actions that are sensitive to positive changes in parent-child interactions.

Behavioral: DEAL

Interventions

DEALBEHAVIORAL

The DEAL protocol is an Acceptance and Commitment Therapy and Behavioral Activation informed clinical protocol to undermine accommodation and help parents adhere with behavioral treatment plan components.

Treatment + DEAL

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Child under the age of 18 years,
  • Child is diagnosed with ASD, as confirmed by the Gilliam Autism Rating Scale-3,
  • Child problem behavior is socially-maintained as identified via functional analysis,
  • Parent is English-speaking, and
  • Parent attendance of at least 80% of appointments at entry into the study.

You may not qualify if:

  • Child is older than 18 years of age,
  • Child does not have ASD,
  • Child's problem behavior is not socially-maintained,
  • Parent does not speak English, and
  • Parent attendance at time of study entry is less than 80%.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kennedy Krieger Institute

Baltimore, Maryland, 21205, United States

Location

Kennedy Krieger Institute

Columbia, Maryland, 21046, United States

Location

MeSH Terms

Conditions

Mental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2022

First Posted

February 14, 2022

Study Start

June 21, 2022

Primary Completion

November 4, 2024

Study Completion

November 4, 2024

Last Updated

February 28, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

There is not a plan at this time for individual participant data sharing outside of resultant published data. The analytic plan for this trial includes within and between participant analyses. These data may be available at some point in time by specific request.

Locations